These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 21113051

  • 1. Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'.
    Liberati A, D'Amico R.
    Int J Epidemiol; 2010 Dec; 39(6):1582-3. PubMed ID: 21113051
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D, Middelburg RA, Egger M, Vandenbroucke JP, Dekkers OM.
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E.
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [Abstract] [Full Text] [Related]

  • 9. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Dorhout Mees EJ.
    Ned Tijdschr Geneeskd; 2000 Nov 11; 144(46):2228. PubMed ID: 11103264
    [No Abstract] [Full Text] [Related]

  • 10. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G, Bretz F, Hothorn LA, Guiard V.
    Stat Med; 2006 Apr 15; 25(7):1131-47. PubMed ID: 16217842
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Wangge G, Klungel OH, Roes KC, de Boer A, Hoes AW, Knol MJ.
    Clin Pharmacol Ther; 2010 Sep 15; 88(3):420-3. PubMed ID: 20668448
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design and analysis of non-inferiority mortality trials in oncology.
    Carroll K, Milsted B, Lewis JA.
    Stat Med; 2004 Sep 15; 23(17):2771-4; author reply 2774-8. PubMed ID: 15316946
    [No Abstract] [Full Text] [Related]

  • 15. Issues in the meta-analysis of cluster randomized trials.
    Donner A, Klar N.
    Stat Med; 2002 Oct 15; 21(19):2971-80. PubMed ID: 12325113
    [Abstract] [Full Text] [Related]

  • 16. Non-inferiority study design: lessons to be learned from cardiovascular trials.
    Head SJ, Kaul S, Bogers AJ, Kappetein AP.
    Eur Heart J; 2012 Jun 15; 33(11):1318-24. PubMed ID: 22564354
    [Abstract] [Full Text] [Related]

  • 17. Issues of study design and data analysis.
    D'Agostino RB.
    Inflamm Bowel Dis; 1998 May 15; 4(2):109-111; discussion 111-3. PubMed ID: 9687216
    [No Abstract] [Full Text] [Related]

  • 18. Blinding during data analysis and writing of manuscripts.
    Gøtzsche PC.
    Control Clin Trials; 1996 Aug 15; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
    [No Abstract] [Full Text] [Related]

  • 19. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM, Wang SJ, O'Neill R.
    Biom J; 2005 Feb 15; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [Abstract] [Full Text] [Related]

  • 20. [Systematic review of the literature--an instrument to capture research results].
    Malmivaara A.
    Duodecim; 2002 Feb 15; 118(9):877-9. PubMed ID: 12238165
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.